Harvesting Cells for Experimental Cancer Treatments
Enrolling by invitation
7,000 enrolled
PROVIDENCE
Recruiting
800 enrolled
Signature Development and Validation Protocol for an Epigenetic Assay in Diagnosing Breast Cancer
Not yet recruiting
450 enrolled
RESONATE
Completed
335 enrolled
PDM-MBC
Active not recruiting
97 enrolled
HER2 CR
Active not recruiting
50 enrolled
Study to Compare Overall Survival in Medicare Patients With Metastatic Breast Cancer Treated With a Medicine Called Palbociclib in Combination With Aromatase Inhibitor and Aromatase Inhibitor by Itself.
Completed
779 enrolled 9 charts
Safety and Efficacy Real-world Data of Trastuzumab Deruxtecan and Sacituzumab Govitecan
Completed
312 enrolled
NIR-II
Recruiting
60 enrolled
Artificial Intelligence Model-Assisted Accurate Diagnosis of Early-Stage Breast Cancer
Not yet recruiting
900 enrolled
START
Terminated
10 enrolled
Integrin αvβ6-targeted PET in Malignant Tumors
Recruiting
200 enrolled
Using Imaging Data and Genomic Data to Predict Metastasis of Breast Cancer After Treatment
Terminated
95 enrolled
REGISTEM
Recruiting
1,867 enrolled
PALMARES-2
Recruiting
3,500 enrolled
REFLECT
Recruiting
120 enrolled
L2-268
Recruiting
80 enrolled
NIR-II
Recruiting
40 enrolled
The Impact of Radiotherapy on Oligometastatic Cancer
Recruiting
2,000 enrolled
CCR4-NOT
Completed
90 enrolled
Identification of Benign and Malignant Breast Nodules Using Ultrasound-modulated Optical Tomography: A Multicenter Study
Recruiting
2,000 enrolled
CER
Recruiting
15,000 enrolled
Assessing Functional Status Needs Via PRO Measures for Pts With Metastatic Breast Cancer
Completed
50 enrolled
MINDACTRelapse
Terminated
31 enrolled
BIO-META
Unknown
10,000 enrolled
Characterization of Circulating Tumor Cells (CTC-s) in Patients With Locally Advanced or Metastatic Stage IV Breast Cancer
Completed
280 enrolled
HOMING
Completed
421 enrolled
CDK4/6 Inhibitors in Patients With Hormone Receptor-positive Advanced Breast Cancer
Recruiting
172 enrolled
Study to Identify Molecular Mechanisms of Clinical Resistance to Chemotherapy in Triple Negative Breast Cancer Patients
Completed
80 enrolled
SPACE2
Unknown
150 enrolled
Preoperative Radiotherapy and Systemic Therapy Following Surgery in 'de Novo' Metastatic Breast Cancer
Recruiting
40 enrolled
E-SPEC
Completed
201 enrolled
RAPANK
Completed
62 enrolled
Effect of Endocrine Therapy Duration on Clinical Outcome of Patients With HR+ Intraductal Carcinoma of the Breast
Unknown
1,354 enrolled
PIONEER
Unknown
1,000 enrolled
IMET
Unknown
300 enrolled
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
Completed
3,571 enrolled
Feasibility Study of Genomic Profiling Methods and Timing in Tumor Samples
Completed
45 enrolled
A Study of Patients With HER2 Gene Amplified Metastatic Breast Cancer Treated With First Line Herceptin and a Taxane
Completed
1,000 enrolled
Assessment of Cardiotoxicity by Cardiac Magnetic Resonance (CMR) in Breast Cancer Patients Receiving Trastuzumab
Unknown
50 enrolled
Metastatic Breast Cancer in Brazil: Characterization of Patients and Treatments
Completed
767 enrolled
MAP-IT
Completed
121 enrolled
Whole Body Magnetic Resonance Imaging (MRI) for Detection of Cancer Metastases
Completed
32 enrolled
WBMRI
Withdrawn
AMBRA
Unknown
1,500 enrolled
Validation Study Using the GeneSearch BLN Assay to Test Sentinel Lymph Nodes From Patients With Breast Cancer
Completed
80 enrolled
GeneSearch Breast Lymph Node (BLN) Assay Timing Study
Terminated
233 enrolled
GeneSearchâ„¢ Breast Lymph Node (BLN) Assay Post Approval Study
Terminated
461 enrolled
Long-term Outcome of HER2-amplified Metastatic Breast Cancer: A Retrospective Analysis
Unknown
100 enrolled
MBC
Completed
52 enrolled